✦ LIBER ✦

278 5 fluorouracil (5FU), and cisplatinum (CDDP) as a circadian chemotherapy plus navelbine (NVB), against stage III B and IV non small cell lung cancer (NSCLC) — A phase I–II study

✍ Scribed by Poirie, P.; Girodet, B.; Laennec, E.; Ardiet, J.M.; Carrie, C.; Martinez, A.; Vincent, M.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I-II trial of cisplatin (CDDP),

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 180 KB

Circadian chemotherapy against stage III

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 149 KB

1099 Cisplatin (CDDP), 5-fluorouracil (5

✍ Livartowski, A.; Dierick, A.; Beuzeboc, P.; Paraiso, D.; Pouillart, P. 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 159 KB

A phase II study of navelbine® (NVB) and

✍ Depperman, KM; Kurzeja, A; Krause, K; Müller, U; Le Bras, F; Delchambre, J; Barb 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 257 KB

A phase II study of navelbine® (NVB) and

✍ Deppermann, KM; Kurzeja, A; Krause, K; Müller, U; Le Bras, F; Delchambre, J; Bar 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 132 KB

129 Chemotherapy with cisplatinum (CDDP)

✍ Janicot, H.; Nguyen, L.; Porthault, E.; Belhadj, H.; Albuisson, E.; Bobichon, I. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 151 KB